Delray Beach, Fla. – – September 10, 2026 -- The global laboratory glassware market is projected to grow from USD 7,630 million in 2026 to USD 9,170 million by 2031, a compound annual growth rate of 4.0%, according to new data from MarketsandMarkets.
Plasticware commands 68% of market share as labs shift away from traditional glass
Plasticware, which includes pipettes, beakers, racks, bottles and containers, accounted for 68% of the laboratory glassware market in 2025. Within this segment, polyethylene products are forecast to post the fastest growth rate in the category, at 4.5% CAGR between 2026 and 2031. The shift reflects laboratory demand for lightweight, shatter-resistant, single-use consumables that improve contamination control and reduce costs across pharmaceutical, biotechnology, contract research organization and food & beverage labs.
Pipettes lead product demand while research institutes drive largest end-user share
Pipettes represented the largest product segment in 2025. Research and academic institutes accounted for 34% of end-user demand the same year, supported by expanding public-sector science funding directed toward multi-omics, photonics, quantum sensing and biomanufacturing research. Centralized procurement programs at these institutions continue to sustain demand for borosilicate and quartzware requiring calibrated, standardized specifications.
Asia Pacific set for fastest regional growth on outsourcing and manufacturing expansion
Asia Pacific is expected to register the highest growth rate of any region through the forecast period, driven by increasing outsourcing of research and manufacturing activity to lower-cost markets with access to skilled labor. Expanding pharmaceutical and biotechnology manufacturing footprints across the region are expected to lift consumable demand.
Market remains fragmented, leaving room for consolidation among key suppliers
Key players named in the report include Corning, Eppendorf, Gerresheimer AG, Thermo Fisher Scientific, Sartorius AG, DWK Life Sciences, Avantor, Merck and Borosil Scientific. MarketsandMarkets describes the competitive landscape as fragmented, with no single vendor holding dominant control, a structure it says leaves significant room for portfolio diversification, geographic expansion and acquisition activity. The market was valued at USD 7,340 million in 2025 before its projected rise to USD 7,633 million in 2026 and USD 9,170 million by 2031.